Entrada Therapeutics, Inc.
TRDA
21 insider filings · Latest: Aug 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2024 | Sep 9 8:27 PM | KORY WENTWORTH | Proposed Sale | 3,195 | $14.80 | $47.3K | — | View → |
| Sep 6, 2024 | Sep 6 8:19 PM | NATHAN DOWDEN | Proposed Sale | 3,150 | $15.39 | $48.5K | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Jun 12 9:34 PM | Kush ParmarDirector, 10% Owner | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 9:17 PM | Peter S KimDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 9:16 PM | Gina ChapmanDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 9:05 PM | Maha RadhakrishnanDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 9:01 PM | Mary ThistleDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 8:52 PM | Bernhardt G ZeiherDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| May 4, 2026 | May 4 11:24 PM | Nathan J DowdenPresident & COO | Option Exercise | 15,000 | $1.74 | 49,831(D) | View → |
| Mar 1, 2026 | Mar 3 11:21 PM | Dipal DoshiDirector, CEO | Grant/Award | 208,000 | $11.93 | 208,000(D) | View → |
| Mar 1, 2026 | Mar 3 11:20 PM | Kory James WentworthChief Financial Officer | Grant/Award | 66,600 | $11.93 | 66,600(D) | View → |
| Mar 1, 2026 | Mar 3 11:19 PM | Nathan J DowdenPresident & COO | Grant/Award | 83,200 | $11.93 | 83,200(D) | View → |
| Mar 1, 2026 | Mar 3 11:18 PM | Natarajan SethuramanPresident, Research & Develop. | Grant/Award | 83,200 | $11.93 | 83,200(D) | View → |